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The DEAD-box protein DDX6 is a central component
of translational repression mechanisms in maternal
mRNA storage in oocytes and microRNA-mediated
silencing in somatic cells. DDX6 interacts with the
CCR4-NOT complex and functions in concert with
several post-transcriptional regulators, including
Edc3, Pat1, and 4E-T. We show that the conserved
CUP-homology domain (CHD) of human 4E-T inter-
acts directly with DDX6 in both the presence and
absence of the central MIF4G domain of CNOT1.
The 2.1-A˚ resolution structure of the corresponding
ternary complex reveals how 4E-T CHD wraps
around the RecA2 domain of DDX6 and contacts
CNOT1. Although 4E-T CHD lacks recognizable
sequence similarity with Edc3 or Pat1, it shares the
same DDX6-binding surface. In contrast to 4E-T,
however, the Edc3 and Pat1 FDF motifs dissociate
from DDX6 upon CNOT1 MIF4G binding in vitro.
The results underscore the presence of a complex
network of simultaneous and/or mutually exclusive
interactions in DDX6-mediated repression.
INTRODUCTION
The CCR4-NOT complex is a conserved multi-protein assembly
that impacts on eukaryotic gene expression at multiple levels
and in organisms ranging from yeast to humans (Chapat and
Corbo, 2014; Collart and Panasenko, 2012). In the cytoplasm,
CCR4-NOT directly controls mRNA stability via the enzymatic
activity of two of its core subunits, the CAF1 and CCR4 deade-
nylases (Tucker et al., 2001;Wahle andWinkler, 2013). Deadeny-
lation is generally the first and rate-limiting step in mRNA
turnover: once the 30 poly(A) tail has been sufficiently shortened,
the 50 cap structure is removed, and the body of the transcript is
swiftly degraded (Chen and Shyu, 2011; Garneau et al., 2007;
Wahle and Winkler, 2013). Shortening of the poly(A) tail not
only stimulates decay but also indirectly reduces translation by
disrupting the association of the poly(A)-binding protein (PABP)Cand its interactions with the eukaryotic translation initiation factor
4F (eIF4F) (Kapp and Lorsch, 2004). However, CCR4-NOT also
appears to control translational efficiency directly. Tethering as-
says have shown that the recruitment of CCR4-NOT to reporter
mRNAs represses their translation in the absence of deadenyla-
tion, both in frog oocytes (Cooke et al., 2010) and upon miRNA-
mediated gene silencing in human cells (Braun et al., 2011; Che-
kulaeva et al., 2011; Fabian et al., 2011). The first physical link
between these different pathways centered at CCR4-NOT has
been recently identified in the direct interaction between the
scaffolding core subunit of the deadenylase complex, CNOT1,
and a known translational repressor and decapping activator,
DDX6 (Chen et al., 2014; Mathys et al., 2014; Rouya et al., 2014).
DDX6 proteins were originally characterized in Drosophila
melanogaster with the discovery of Me31B, a factor involved
in embryonic development. Drosophila Me31B represses the
translation of maternal mRNAs during their transport to the
oocyte (Nakamura et al., 2001) and is important for neuronal ac-
tivity in adult flies, where it localizes in neuronal granules and
controls translation at synapses (Barbee et al., 2006). Similarly,
the Caenorhabditis elegans and Xenopus laevis orthologs
(known as Chg-1 and Xp54) are found in germline granules and
repress the translation of maternal mRNAs that are stored in
these large ribonucleoprotein particles (RNPs) for subsequent
activation (Boag et al., 2008; Ladomery et al., 1997). In humans,
DDX6 (also known as RCK) is expressed in a variety of tissues (Lu
and Yunis, 1992), is connected to chromosomal aberrations in
several cancers (Robert and Pelletier, 2013), and participates
as a translational repressor in different pathways, including
mRNA storage in erythropoiesis (Ostareck-Lederer and Ostar-
eck, 2012) and microRNA (miRNA)-mediated gene silencing
(Chen et al., 2014; Chu and Rana, 2006; Mathys et al., 2014;
Rouya et al., 2014). Finally, the Saccharomyces cerevisiae ortho-
log Dhh1 is able to repress translation (Carroll et al., 2011; Coller
and Parker, 2005), but its best studied function is in the enhance-
ment of mRNA decapping and decay (Coller et al., 2001; Fischer
and Weis, 2002). In tissue culture cells, all DDX6 orthologs stud-
ied to date localize in RNP aggregates known as processing (P)-
bodies, which also contain RNA decay factors (Anderson and
Kedersha, 2006; Eulalio et al., 2007; Sheth and Parker, 2006).
DDX6 is a very abundant protein that belongs to the DEAD-box
family of RNA-dependent ATPases (Ozgur et al., 2015; Presnyakell Reports 13, 703–711, October 27, 2015 ª2015 The Authors 703
and Coller, 2013; Russell et al., 2013). It features the character-
istic tandem of RecA-like domains (RecA1 and RecA2) but also
has the unusual property of existing primarily in an autoinhibited
conformation that can bind RNA in a non-productive, ATP-inde-
pendent manner (Cheng et al., 2005; Dutta et al., 2011; Sharif
et al., 2013). DDX6 coats repressed mRNA and has a potential
to oligomerize (Ernoult-Lange et al., 2012). The ATPase activity
of DDX6 is stimulated upon binding to the central MIF4G domain
of CNOT1, which primes DDX6 toward its active conformation
(Mathys et al., 2014). DDX6 activity is essential for miRNA
silencing (Chen et al., 2014; Mathys et al., 2014; Rouya et al.,
2014) and for P-body assembly (Minshall et al., 2009; Ozgur
and Stoecklin, 2013). Paradoxically, the RecA2 domain alone is
sufficient for translational repression in tethering assays (Min-
shall et al., 2009). This may be a consequence of the RecA2
domain of DDX6 having the ability to interact with other regulato-
ry proteins. Edc3 and the Edc3-related protein Lsm14 (also
known as Tral, Scd6, or RAP55) interact with DDX6 RecA2
through their Phe-Asp-Phe (FDF) motifs (Tritschler et al., 2008).
In turn, Edc3 and Lsm14 directly bind and activate the decapping
complex, DCP1-DCP2 (Fromm et al., 2012; Nissan et al., 2010;
Tritschler et al., 2008). DDX6 also uses the same Edc3/Lsm14-
binding surface to interact with Pat1 (Sharif et al., 2013), another
modulator of mRNA stability and translation (Marnef and Stand-
art, 2010).
Several lines of evidence point to 4E-T (eIF4E transporter)
as a key translational repressor closely connected to DDX6.
Biochemical studies in early Xenopus oocytes have shown that
4E-T co-purifies with Xp54/DDX6, Pat1, Lsm14, and the cap-
binding protein eIF4E as part of a messenger RNP (mRNP) that
stores silenced maternal mRNAs (Minshall et al., 2007). The
D. melanogaster and C. elegans orthologs (CUP and IFET-1)
also function as translational repressors acting in early develop-
ment (Nakamura et al., 2004; Nelson et al., 2004; Sengupta et al.,
2013). Similarly, 4E-T represents an essential component of the
translation repressive complex in mouse neuronal progenitors
(Yang et al., 2014). In tether-function studies, human 4E-T and
Drosophila CUP inhibit the translation of reporter mRNAs to a
level comparable to that of DDX6 (Ferraiuolo et al., 2005; Igreja
and Izaurralde, 2011; Kamenska et al., 2014a). This protein fam-
ily contains a canonical eIF4E-binding motif, analogous to that
used by a diverse group of translational repressors for seques-
tering eIF4E, disrupting the eIF4F complex and impairing trans-
lation initiation (Kamenska et al., 2014b). Surprisingly, however,
4E-T and CUP can exert their repressive activity even indepen-
dently from eIF4E (Igreja and Izaurralde, 2011; Kamenska
et al., 2014a). The mechanism underlying 4E-independent trans-
lational repression is currently unclear. Here, we used biochem-
ical and structural approaches to understand how DDX6 might
function, together with 4E-T, in the context of the CCR4-NOT
complex and of the DDX6-binding proteins Edc3 and Pat1.
RESULTS AND DISCUSSION
The Conserved CHD Region of 4E-T Interacts with the
RecA2 Domain of DDX6
4E-T and DDX6 are found together spatially and temporally in
different biological contexts (Kamenska et al., 2014b; Presnyak704 Cell Reports 13, 703–711, October 27, 2015 ª2015 The Authorsand Coller, 2013). We performed co-immunoprecipitation (co-
IP) assays in human HEK293T cells. We transiently expressed
yellow fluorescent protein (YFP)-tagged 4E-T and hemagglutinin
(HA)-tagged DDX6, either wild-type or mutants (Figure 1B), and
used GFP-binder beads for the precipitations. In these assays,
DDX6 interacted with 4E-T (Figure 1B). The RecA2 domain of
DDX6 is an interaction hotspot for different proteins. It contains
an FDF-binding surface (the so-called patch 1 surface) that binds
the FDF motifs of Edc3, Lsm14, and Pat1. Two other surfaces of
DDX6 (known as patch 2 and patch 3) are also engaged in inter-
actions with Edc3-related proteins and/or Pat1 (Sharif et al.,
2013; Tritschler et al., 2009). We tested DDX6 mutants known
to disrupt the interaction with both Edc3 and Pat1, namely, mu-
tations in patch 1 (DDX6mut1) and patch 3 (DDX6mut3) (Sharif
et al., 2013; Tritschler et al., 2009). We found that both abolished
the interaction with 4E-T (Figure 1B). The RecA2 domain of DDX6
also interacts with CNOT1 (Chen et al., 2014; Mathys et al., 2014;
Rouya et al., 2014). We tested a single amino acid substitution in
DDX6 (DDX6mif3) that is known to abrogate binding to CNOT1
(Mathys et al., 2014). Importantly, DDX6mif3 did not affect the
DDX6 interaction with 4E-T (Figure 1B). We concluded that the
Edc3/Pat1-binding surfaces in the RecA2 domain of DDX6 are
required for the interaction with 4E-T, while the CNOT1-binding
surface of DDX6 is dispensable.
Human 4E-T is predicted to be largely unstructured. Besides
the 4E-binding motif at the N terminus of the molecule (Dostie
et al., 2000; Ferraiuolo et al., 2005) and a P-body localization re-
gion at the C terminus (Kamenska et al., 2014a), themost striking
feature at the sequence level is a short segment that is highly
conserved in the 4E-T family of proteins and has been termed
theCUP-homology domain (CHD; residues 208–240) (Kamenska
et al., 2014a) (Figure 1A). Another interesting region in the
sequence of 4E-T is between residues 302 and 328, as it features
an FDF-like motif (discussed later). Although the experiments in
Figure 1B suggested that 4E-T is recognized at the FDF-binding
site, a mutant of 4E-T whereby the FDF-containing motif had
been removed still retained the ability to interact with DDX6 in
co-IP assays (Figure 1C, 4E-TDFDF mutant). Counterintuitively,
removal of the CHD, which does not contain a recognizable
FDFmotif, decreased DDX6 binding to a larger extent (Figure 1C,
4E-TDCHDmutant). Removal of both the CHD and FDF-like motifs
of 4E-T had an additive effect in impairing the DDX6 interaction
(Figure 1C).We concluded that theCHD is amajor DDX6-binding
segment of 4E-T. We note that the laboratory of Marc Fabian
independently reached a similar conclusion in a recent paper
(Nishimura et al., 2015) that was published while this manuscript
was being reviewed.
Structure of the Ternary Complex of 4E-T CHD, DDX6,
and CNOT1 MIF4G
We recapitulated the interactions observed in co-IP assays using
in vitro reconstitutions with purified recombinant proteins.
Human 4E-T CHD was co-expressed with the RecA2 domain
of DDX6, and the two proteins were co-purified, forming a binary
complex in size exclusion chromatography (Figure S1). Next, we
tested the interaction with CNOT1. To this end, we co-expressed
and co-purified a binary complex of 4E-T CHD and a DDX6 frag-
ment containing both RecA domains (hereinafter referred to as
AB
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Figure 1. The 4E-T CHD Motif Interacts with the RecA2 Domain
of DDX6
(A) Schematic representation of the domain arrangements of human DDX6 and
4E-T. In color are the portions of the molecules characterized in this study. The
DEAD-box protein DDX6 has the two characteristic RecA domains (in blue).
Within 4E-T, the CHD (residues 208–240, in magenta) and the FDFmotif similar
to that in Edc3 or Pat1 (FDF, residues 302–328, in pink) provide major
and minor DDX6-binding sites, respectively. In light and dark gray are two
other regions of 4E-T that have been previously characterized, namely, the
N-terminal eIF4E-binding site and the C-terminal P-body localization site,
respectively.
CDDX6 core, or DDX6C) and incubated it with a CNOT1 fragment
encompassing the central MIF4G domain (hereinafter referred
to as CNOT1 MIF4G). The three proteins co-eluted in size-
exclusion chromatography, forming a 1:1:1 complex (Figure 1D).
We determined the crystal structure of the 4E-T CHD/DDX6C/
CNOT1 MIF4G complex to a 2.1-A˚ resolution and refined it to
an Rfree of 23.2%, an Rfactor of 19.3%, and good stereochemistry
(Table 1). The final model includes residues 216–238 of 4E-T,
residues 95–462 of DDX6, and residues 1065–1309 of CNOT1.
The structure of the DDX6C/CNOT1 MIF4G portion of the
ternary complex is similar to that of the binary complex previ-
ously described (Mathys et al., 2014). The MIF4G of CNOT1
has a crescent shape with a core that is formed by five tandem
HEAT repeats. The convex surface of CNOT1 MIF4G that is
used to interact with Caf1 (Basquin et al., 2012; Petit et al.,
2012) is exposed to solvent (Figure 2, left panel). The concave
surface of CNOT1 MIF4G faces DDX6C and uses the first and
last HEAT repeats of the crescent to contact the RecA2 and
RecA1 domains, respectively (Figure 2, left panel). Each RecA
domain of DDX6C is formed of a flat, parallel b sheet sandwiched
between two layers of a helices. The bottom of RecA2 (defined
as the surface where the parallel b strands start) interacts with
the B helix of MIF4G HEAT 1 using a pocket centered at DDX6
Arg386 (the residue substituted in the mif3 mutant discussed
earlier). RecA1 contacts CNOT1 MIF4G at the B helix of HEAT
5 (Figure 2, left panel).
In the structure of the ternary 4E-T/DDX6C/CNOT1 MIF4G
complex, the two RecA domains of DDX6C face each other
and are separated by 10 A˚. This conformation is essentially
identical to that of the binary DDX6C/CNOT1 MIF4G complex
and is similar to the conformation adopted by the DEAD-box
proteins eIF4A and Dbp5 when in complex with their MIF4G
partners, eIF4G and Gle1 (Mathys et al., 2014; Montpetit
et al., 2011; Sch€utz et al., 2008). As previously observed, this(B) Co-IP assays of H. sapiens HA-DDX6 with YFP-4E-T (in 150 mM NaCl).
Wild-type and mutants were transiently transfected in HEK293T cells. Cell
lysates (input) were immunoprecipitated with GFP binder, and eluted HA- and
YFP-tagged proteins were detected by western blotting. DDX6mut1 (Q320A,
H323A, T327A and R331A) impairs the FDF-binding site used for binding Pat1
and Edc3. DDX6mut3 (S343D, Q345D, and R346D) impairs a surface patch
used for Pat1, but not Edc3, binding. DDX6mif3 (R386E) impairs CNOT1
binding. For the inability of these mutants to pull down Pat1, Edc3, or CNOT1,
see Mathys et al. (2014), Sharif et al. (2013), and Tritschler et al. (2009).
(C) Co-IP of YFP-tagged 4E-T (either wild-type or mutants) with HA-tagged
DDX6. The IP was done as described above, except that higher NaCl con-
centration (300 mM) was used in washes to better compare the relative con-
tributions of the CHD and FDF motifs toward DDX6 binding. The deletion
mutants 4E-T DCHD, DFDF, and DCHD-DFDF lack residues 208–240, 302–
328, and 208–240 and 302–328, respectively.
(D) DDX6C/4E-T interaction with recombinant proteins. DDX6C (residues 95–
469) was co-expressed with the 4E-T CHD region (detailed in A), purified, and
analyzed by size exclusion chromatography in the absence (peak 1) or pres-
ence (peak 2) of the CNOT1MIF4G domain (Superdex 75_PC 3.2/300 column,
GE Healthcare; exclusion volume, 0.8 ml). On the left are the overlays of the
chromatograms (mAU and Vr denote relative absorbance and retention
volume of the proteins, respectively). On the right is the Coomassie-stained
SDS-PAGE gel with the samples from the corresponding peak fractions. Star
indicates contamination.
See also Figure S1.
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Table 1. Data Collection and Refinement Statistics
Statistic 4E-T/CNOT1/DDX6
Wavelength (A˚) 1
Resolution range (A˚)a 47.32–2.102 (2.177–2.102)
Space group P 32 2 1
Unit cell 93.129, 93.129, 175.329
a, b, g () 90, 90, 120
Total reflectionsa 488,786 (34,933)
Unique reflectionsa 51,910 (5,023)
Multiplicitya 9.4 (7.0)
Completeness (%)a 99.74 (97.44)
Mean I/s(I)a 17.61 (1.60)
CC1/2a 0.999 (0.806)
Rmerge
a 0.09499 (1.041)
Rwork
a 0.1931 (0.3400)
Rfree
a 0.2319 (0.3688)
Number of non-hydrogen atoms
Total 5,205
Proteins 4,929
RMSD (bonds) 0.008
RMSD (angles) 1.09
Ramachandran favored (%) 97
Ramachandran outliers (%) 0.16
Average B factor 46.0
This table shows data collection and refinement statistics. Values for the
highest resolution shell are given in parentheses. Structure validation was
carried out with MolProbity (Chen et al., 2010). RMSD, root-mean-square
deviation.
aStatistics for the highest resolution shell are shown in parentheses.conformation approaches the structure that DEAD-box proteins
adopt when in the active state (Mathys et al., 2014; Montpetit
et al., 2011; Sch€utz et al., 2008) (Figure 2, right panel). In the
active state, RNA is expected to bind in a shallow surface
groove near the top surfaces of the two RecA domains, while
ATP is expected to bind in a deep wedge on the opposite
side of the molecule (Ozgur et al., 2015). 4E-T zig-zags around
the N-terminal helical layer of RecA2 and contacts CNOT1
MIF4G.
4E-T CHD Interacts with DDX6 at the SameHydrophobic
Pockets Used by Edc3 and Pat1
4E-T CHD binds DDX6C in an extended conformation, burying
more than 1,000 A˚2 of solvent-exposed area. The interaction is
mediated by evolutionarily conserved amino acids (Figure 3A).
Two hydrophobic residues of 4E-T (Ile233 and Leu235) bind
the patch 1 surface of DDX6C via Van der Waals contacts with
Cys324, Ile435, and Leu328 (Figure 3B, upper panel). 4E-T
Ile233 and Leu235 are part of an IEL sequence motif and occupy
the equivalent positions of the two phenylanine side chains in the
FDF motifs of Edc3-related and Pat1 proteins (Figure 3B; Fig-
ure S2). In addition, the negatively charged residue in the IEL
motif (Glu234) forms a salt bridge with DDX6C Arg331. Proceed-
ing toward the C terminus of the CHD, 4E-T Phe238 binds part of706 Cell Reports 13, 703–711, October 27, 2015 ª2015 The Authorsthe patch 2 surface of DDX6C via Van der Waals contacts with
Tyr315. Edc3 orthologs from both human and yeast feature
a phenylalanine residue at the equivalent position of 4E-T
Phe238. However, the two proteins use different structural ele-
ments to cover the distance between patch 1 and patch 2 (an
a-helix and a short glycine-containing segment, respectively)
(Figure 3B; Figure S2).
Proceeding from the IEL motif toward the N terminus of the
CHD, the 4E-T polypeptide chain makes a turn and wedges be-
tween two helices of RecA2, contacting CNOT1. Here, in addi-
tion to backbone-mediated interactions, the aliphatic portion of
4E-T Gln229 packs against the side chain of CNOT1 Phe1096.
The 4E-T chain then folds into a short coil and inserts the side
chains of Trp221 and Phe222 to interact with the patch 3 surface
of DDX6C (formed by E318, H323, R346, L349, and K353) (Fig-
ure 3B). Both Edc3 and Pat1 orthologs feature a large aromatic
residue at the equivalent position of 4E-T Trp221 (Figure 3B;
Figure S2). Finally, at the N terminus of the CHD, a cluster of
negatively charged amino acids binds near the top surface of
the RecA2 domain (Figure 3B).
We concluded that 4E-T uses non-canonical sequence motifs
to bind the same apolar pockets of DDX6C that are used for
recognizing Edc3, Lsm14, and Pat1, rationalizing the effect of
the DDX6 mutants shown in Figure 1B. Also, consistent with
the structural analysis, 4E-T substitutions of Trp221Ala (4E-
TWmut) or Trp221Ala, Phe222Ala (4E-TWFmut) impaired DDX6
binding in co-IP assays (Figure 3C).
Flanking Residues in the FDF-like Motifs of
DDX6-Binding Proteins Regulate the Interaction with
CNOT1 MIF4G
The DDX6-binding domains of human Edc3 (residues 170–211)
and Pat1 (residues 13–50) have been previously established
(Sharif et al., 2013; Tritschler et al., 2009). We purified the corre-
sponding Edc3/DDX6C and Pat1/DDX6C complexes and pro-
ceeded to add CNOT1 MIF4G. Unexpectedly, binding of
CNOT1 MIF4G to DDX6C resulted in the dissociation of both
Edc3 and Pat1 (Figures 4A and 4B). Careful comparison of the
available structures of DDX6-bound complexes pointed to an
interesting difference. In the case of 4E-T, the residue preceding
the IEL motif is a conserved polar residue (Thr232), pointing to-
ward a conserved negatively charged amino acid of CNOT1
(Glu1092) (Figure 4C). In the case of Edc3, Lsm14, and Pat1,
the FDF motif is preceded by a conserved negatively charged
residue (Asp203 for yeast Edc3, for example) (Figure 4C). Struc-
tural superpositions suggested that a negatively charged side
chain at this position would result in electrostatic unfavorable
interactions with CNOT1 Glu1092. To test this prediction, we en-
gineered a Thr232Asp (T232D) substitution in 4E-T. In vitro, addi-
tion of CNOT1MIF4G to the 4E-T T232D/DDX6C complex indeed
displaced 4E-T (Figure 4D), suggesting that seemingly small
differences in the sequence of different DDX6-binding proteins
allow or disfavor binding when complexed with CNOT1 MIF4G.
We note, however, that because of the multidomain organization
of 4E-T and CNOT1 and their involvement in complex networks
of protein-protein and protein-RNA interactions, there might
be additional direct or indirect interaction sites outside the
CNOT1 MIF4G. Indeed, the interaction of full-length 4E-T with
Figure 2. Structure of the Ternary Complex
of DDX6C, CNOT1 MIF4G, and 4E-T CHD
On the left, structure of the complex with the core
of the DEAD-box protein DDX6, DDX6C, in blue,
4E-T CHD in magenta, and the central MIF4G
domain of CNOT1 in yellow. The N- and C-terminal
residues of the 4E-T CHD region ordered in the
structure are indicated. For comparison, on the
right is the structure of a related DEAD-box protein,
Dbp5, in the active conformation bound to and
ATP analog and RNA (in black) (PDB: 3FHT) (von
Moeller et al., 2009). The two structures are shown
in the same orientation after optimal superposition
of their RecA2 domains.full-length CNOT1 was unaffected by the T232 substitution in
4E-T (Figure S3). This finding is consistent with recent observa-
tions of Nishimura et al. (2015) that the interaction of 4E-T with
either DDX6 or CNOT1 can also be affected, either positively
or negatively, by additional proteins such as Lsm14 and Pat1
(via their interaction with DDX6) or TTP (via its interaction
with CNOT1). Furthermore, treatment of samples with RNase
A during the co-IP assays resulted in stronger interaction with
CNOT1 and reduced the DDX6 interaction (Figure S3). This
observation suggests that, despite the direct interaction be-
tween 4E-T CHD and DDX6, mRNA has an important role in re-
arranging these interactions in vivo.
Conclusions
DDX6 functions in a wide range of translational repression path-
ways that ultimately lead to either mRNA degradation (e.g., in
miRNA-mediated gene silencing) or mRNA storage (e.g., in
germline and neuronal granules). It is currently thought that the
different outcomes of translation repression might depend on
the factors DDX6 binds to (Presnyak and Coller, 2013). Although
DDX6 is similar to other DEAD-box proteins in terms of sequence
and fold, it has distinctive surface features that underpin the
direct interaction with specific regulatory proteins. One of the in-
teracting proteins is the CNOT1 core subunit of the CCR4-NOT
complex (Chen et al., 2014; Mathys et al., 2014; Rouya et al.,
2014). The central MIF4G domain of CNOT1 regulates the cata-
lytic activity of DDX6 by favoring the transition from the inactive
to the active conformation of the ATPase (Mathys et al., 2014)
and, at the same time, incorporates DDX6 to the CCR4-NOT
complex. Another set of DDX6-interacting proteins includes
Pat1 (Sharif et al., 2013), Edc3, Lsm14 (Tritschler et al., 2009),
and—as shown here and also in other studies (Ayache et al.,
2015; Nishimura et al., 2015)—4E-T. These proteins share
several architectural features. First, they are mainly unstructured
and presumably flexible. Second, they have a modular organi-
zation, with separate segments serving as platforms for pro-
tein-protein interactions, including association with DDX6.
Importantly, our structural analysis has revealed that Pat1,
Edc3, Lsm14, and 4E-T regulators are recognized by the same
side surface of the DDX6 RecA2 domain.CThe side surface of theDDX6RecA2domain is characterized by
threehydrophobichotspots.Themostprominenthotspot (patch1)
was originally called the FDF-binding site because of the
conserved short, interacting sequence motif found in Edc3 and
Lsm14 (Tritschler et al., 2009). Although the CHD of 4E-T wraps
around RecA2 with the same directionality observed in the case
of Edc3 and Pat1 (threading from patch 3 to patch 1 and, finally,
topatch2), it lacks anFDFmotif and, instead, usesdifferent apolar
sequence motifs connected by unrelated linker sequences to
occupy the three hydrophobic hotspots. With hindsight, the inter-
action of 4E-T CHD could not be predicted by sequence analysis,
and it is possible that, in the future, other proteins will be found to
interact with DDX6 via ‘‘concealed’’ sequence motifs. The DDX6
CNOT1-binding region is adjacent to, but separate from, the
side surface of RecA2. Our in vitro studies show that only 4E-T
can interact with DDX6 concomitantly with the CNOT1 MIF4G
domain. Surprisingly, Edc3 and Pat1 binding to DDX6 results
in localized, unfavorable electrostatic effects, leading to their
displacement upon binding of the CNOT1 MIF4G domain.
The implication of themutually exclusive interactions identified
from the structural analyses of DDX6 bound to Edc3 (Tritschler
et al., 2009), Pat1 (Sharif et al., 2013), and 4E-T (the present
article) is that a given DDX6 molecule can bind only one of the
partners at a time. Different scenarios can be envisaged. In
one model, the individual proteins could be recruited sequen-
tially, with each binding event representing a progressive step
in the pathway. For example, binding of 4E-T to DDX6 could
occur first in the context of the CCR4-NOT complex. Following
translational repression and deadenylation, Edc3 could displace
4E-T from DDX6 and tether DDX6 to the decapping complex
(Fenger-Grøn et al., 2005; Tritschler et al., 2008). Pat1 binding
to DDX6 would, instead, tether DDX6 to the Lsm1-7 complex
(Ozgur et al., 2010; Sharif and Conti, 2013). In an alternative
model, these interactions could reflect the existence of different
complexes that perform related functions and that could exist
either in isolation or in combination in large mRNP granules.
This possibility is plausible because DDX6 is 10 to 20 times
more abundant than other regulators (Beck et al., 2011; Nagaraj
et al., 2011) and can thus participate in different complexes
simultaneously. Importantly, our in vitro studies suggest thatell Reports 13, 703–711, October 27, 2015 ª2015 The Authors 707
AB
C Figure 3. The 4E-T CHD Domain, Edc3, and
Pat1 Bind at the Same Surfaces of DDX6
(A) Structure-based sequence alignment of the
4E-T CHD region from H. sapiens (Hs),D. rerio (Dr),
X. laevis (Xl), C. elegans (Ce), and D. melanogaster
(Dm) CUP. Conserved residues are highlighted in
magenta boxes. Residues of 4E-T interacting with
DDX6C and with CNOT1 MIF4G are indicated
above the sequences with blue and yellow
circles, respectively. The alignment also includes
the DDX6-binding domains of Edc3 and Pat1 and
of the 4E-T FDF region.
(B) Zoom-in of the interaction surfaces of 4E-T and
DDX6C/CNOT1 MIF4G in two orientations, with
interacting residues in stick representation and
labeled. The lower panels show the comparison
with the interaction surfaces of yeast Edc3 and the
yeast DDX6 ortholog Dhh1 (PDB: 4BRU), in the
same orientations after optimal superposition.
(C) HEK293T cells were transiently transfected
with FLAG-GFP, FLAG-4E-T, and FLAG-4E-T
mutants WFmut (Trp221Ala, Phe222Ala) and
Wmut (Trp221Ala). Lysates were immunoprecipi-
tated using FLAG-M2 antibody beads, and eluted
proteins were analyzed by SDS-PAGE followed by
western blotting with indicated antibodies.
See also Figure S2.only 4E-T (but neither Edc3 nor Pat1) would be able to bind DDX6
in the ATPase-competent conformation that is triggered by the
interaction with the CNOT1 MIF4G domain. Finally, 4E-T is ex-
pected to interact not only with DDX6 and, indirectly, CNOT1
MIF4G via the CHD region but also with eIF4E cap-binding pro-
teins via the N-terminal region and, as shown by Nishimura et al.
(2015), with Pat1 and Lsm14 through other protein regions. The
concomitant presence of multiple repressive complexes would
provide redundancy and reinforce the robustness of translational
repression.708 Cell Reports 13, 703–711, October 27, 2015 ª2015 The AuthorsDemonstration that 4E-T can associate
with DDX6, even when the latter is in com-
plex with the CNOT1 MIF4G, makes 4E-T
a plausible candidate for the downstream
effector in the GW182/CCR4-NOT/DDX6
axis, which functions in mediating trans-
lational repression by miRNAs. A role of
DDX6 in repression of protein synthesis
in the absence of mRNA deadenylation
and/or decay, regardless of whether
DDX6 is recruited to mRNA by the miRNA
machinery or by direct tethering, is well
documented (Carroll et al., 2011; Mathys
et al., 2014; Minshall and Standart, 2004;
Minshall et al., 2009; Presnyak and Coller,
2013). Likewise, 4E-T can inhibit protein
synthesis in the absence of apparent
mRNA degradation when tethered to
mRNA, and, more importantly, its deple-
tion was recently found to compromise
repression of the miRNA reporter inhuman cells (Kamenska et al., 2014a). 4E-T was also identified
as the translational repressor acting downstream of CNOT1
and DDX6 in Xenopus oocytes (Waghray et al., 2015).
In addition to its documented role in repression of translation,
4E-T has been shown to enhance decay of mRNAs bearing the
30-UTR AU-rich elements (Ferraiuolo et al., 2005). The recent
study of Nishimura et al. (2015) demonstrated that 4E-T, working
together with DDX6 and CCR4-NOT, promotes mRNA decay by
bridging the Lsm1-7/Pat1 complex associated with the mRNA 30
terminuswith the eIF4E bound to the 50 cap. In the future, it will be
AC D
B
Figure 4. The 4E-T CHD Domain but Neither Edc3 Nor Pat1 Are Recruited to CNOT1 via DDX6
(A–D) In (A, B, and D), size exclusion chromatography assays assess formation of protein complexes. Purified samples of DDX6C and its interacting proteins (Edc3
FDF segment, Pat1 FDF-like segment, or 4E-T CHD T232D mutant) were incubated with CNOT1 MIF4G and co-injected on an analytical size exclusion chro-
matography column (Superdex 75_PC 3.2/300 column, GE Healthcare; exclusion volume 0.8 ml). On the left are the overlays of the chromatograms. On the right
are the Coomassie-stained gels with samples from the corresponding peak fractions. Star indicates contamination. (C) Zoom-in at the FDF-binding site of DDX6C.
The structure of 4E-T/DDX6C/CNOT1 MIF4G (with three proteins in magenta, blue, and yellow, respectively) is shown superposed on that of human Edc3
(in salmon) in complex with the RecA2 domain of DDX6 (PDB: 2WAX) (Tritschler et al., 2009). A conserved negatively charged residue of CNOT1 (E1092) is shown
pointing toward Thr232 of 4E-T. At the corresponding position, Edc3 would feature a conserved negatively charged residue, Asp203. In the sequence alignment
on the right, the corresponding residues are boxed in red or green, depending on whether they are negatively charged (red) or not (green).
See also Figure S3.important to understand how the similar sets of factors, including
proteins of the CCR4-NOT/DDX6/4E-T axis, are programmed to
either inhibit translation or mediatemRNA decapping and decay.
Likewise, it will be essential to establish the exact role of the
CCR4-NOT/DDX6/4E-T pathway in translational silencing.
EXPERIMENTAL PROCEDURES
Protein Purification and Binding Assays
The expression vectors and purification protocols for human DDX6C (residues
95–469) and CNOT1 MIF4G domain (residues 1063–1314) were previously
described (Mathys et al., 2014). Human 4E-T (residues 199–240) was cloned
in a SUMO-tagged vector and co-expressed with DDX6 in BL21(DE3) pLyS
in Terrific Broth (TB) medium. The 4E-T/DDX6C complex was co-purified using
nickel-based affinity chromatography and ion-exchange chromatography at
pH 7.5 (heparin, GE Healthcare), followed by tag cleavage by SENP2 and
size exclusion chromatography (Superdex 75). DDX6C/4E-T CHD was incu-
bated with CNOT1 MIF4G in a 1.5:1 molar ratio and injected on a Superdex
75 in 20 mM Tris (pH 7.4), 250 mM NaCl, 1 mM DTT. Human Pat1 (residues
13–50), Edc3 (residues 170–211), and the 4E-T (residues 199–240) mutant
T232D were co-expressed with DDX6C using analogous vectors and analo-
gous protocols. The binding assayswere performed by size exclusion chroma-
tography as described for 4E-T.
Crystallization and Structure Determination
Crystallization was carried out at 4C using the vapor diffusion method bymix-
ing equal volumes of protein complex at 12 mg/ml and of crystallization buffer.CThe best diffracting crystals of 4E-T CHD/DDX6C/CNOT1 MIF4G complex
were obtained in 50 mM Tris (pH 8.0), 35% MPD (2-methyl-2,4-pentanediol),
after 5 days. Crystals were flash frozen in liquid nitrogen directly from the crys-
tallization drop and diffracted to a 2.1-A˚ resolution. Diffraction data were
collected at 100 K at the beamline X06D (PXIII) of the Swiss Light Source
(SLS) synchrotron and processed using XDS (McCoy et al., 2007). The struc-
tures were determined by molecular replacement with the program Phaser
(Kabsch, 2010), using the structure of CNOT1 MIF4G/DDX6C complex
(4CT4) (Mathys et al., 2014) as the search model. The atomic model was built
with the program Coot (Emsley et al., 2010) and refined with PHENIX (Adams
et al., 2010). The data collection and refinement statistics are summarized in
Table 1.
Co-IP Assays
Co-IP assays on Figure 1 were essentially performed as described previously
(Sharif et al., 2013). For co-IP on Figure 3C, HEK293T cell lysates were
incubated with anti-FLAG-M2 beads (Sigma Aldrich); after washing, bound
proteins were eluted with SDS loading buffer. Western blotting analysis was
performed with 15% SDS-PAGE. The following antibodies were used in the
ECL Western Blotting Detection System (GE Healthcare): rabbit anti-DDX6
(Bethyl Laboratories, A300-461A), Pat1b (Marnef and Standart, 2010), and
mouse anti-FLAG (Sigma, F3165).ACCESSION NUMBERS
The accession number for the coordinates and structure factors of the 4E-T
CHD/DDX6C/CNOT1 MIF4G complex is PDB: 5ANR.ell Reports 13, 703–711, October 27, 2015 ª2015 The Authors 709
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